It's a neuraminidase inhibitor
for influenzzza virus A & B
from a little company biota

Glaxo Smith Kline
attached a writ you will find
sank relenza intentionaly
hurting profits annually

it's strategy relies on the availibility
of crystal structure in the influenza neuraminidase
acheived by crystalography
DANA's been known since 1974

Glaxo Smith Kline
attached a writ you will find
sank relenza intentionaly
hurting profits annually

Biota sued GSK for fail;ing to support relenza
stuck with it's crap ass proprietary disk inhaler

Glaxo Smith Kline
attached a writ you will find
sank relenza intentionaly
hurting profits annually

Zanamivir was the first of neuarminidase inhibitors
it had no commercial success but led the way for future something or others